The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats: Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade

This publication has 14 references indexed in Scilit:

• The atriopeptidase inhibitor (±)candoxatrilat reduces the clearance of atrial natriuretic factor in both intact and nephrectomized rats: evidence for an extrarenal site of action
  Biochemical Pharmacology, 1991
• UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic
  Biochemical and Biophysical Research Communications, 1989
• Metabolism of 125I-atrial natriuretic factor by vascular smooth muscle cells
  Published by Elsevier ,1989
• Identification of structural requirements for analogs of atrial natriuretic peptide (ANP) to discriminate between ANP receptor subtypes
  Journal of Medicinal Chemistry, 1989
• Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney
  Peptides, 1988
• Physiological Role of Silent Receptors of Atrial Natriuretic Factor
  Science, 1987
• The hydrolysis of α-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11
  Biochemical Journal, 1987
• Specific receptors for atriopeptin III in rabbit lung
  Biochemical and Biophysical Research Communications, 1986
• Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man
  Life Sciences, 1986
• Atrial natriuretic factor—a circulating hormone stimulated by volume loading
  Nature, 1985